Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03117972
Title Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels (CLavSyn)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Besancon
Indications

colorectal adenocarcinoma

Therapies

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Bevacizumab + Fluorouracil + Leucovorin

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Capecitabine

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.